Last updated: July 14, 2012
Sponsor: Universidade de Passo Fundo
Overall Status: Completed
Phase
3
Condition
Heartburn
Gastroesophageal Reflux Disease (Gerd)
Heartburn (Pediatric)
Treatment
N/AClinical Study ID
NCT01065649
0102.0.398.000-09
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- more than 17 years old, heartburn at least twice a week, naive to antirefluxmedications and antidepressive agents
Exclusion
Exclusion Criteria:
- active esophagitis at endoscopy, contraindications to nortriptyline use
Study Design
Total Participants: 20
Study Start date:
January 01, 2010
Estimated Completion Date:
June 30, 2010
Connect with a study center
Kozma
Passo Fundo, RS 990010-080
BrazilSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.